Terms ending in 2029
Yeda Research and Development Co. Ltd.
Every in-force patent on Yeda Research and Development Co. Ltd.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,155,488 | Method and Device for Monitoring Breastfeeding In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 9,867,576 | Computer-Accessible Medium, System and Method for Assessing Effect of a Stimulus Using Intersubject Correlation In force · High confidence | Yeda Research and Development Co., Ltd. at the Weizmann Institute of Science | In force | High confidence | |
| US 8,331,017 | Crystal for Optical Conversion In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 8,324,355 | Antibodies and Pharmaceutical Compositions Containing Same Useful for Inhibiting Activity of Metalloproteins In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 8,521,272 | Method and Device for Monitoring Breastfeeding In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 8,889,865 | Process for Preparing Amines from Alcohols and Ammonia Grace period ended Nov 18, 2026 · lapse expected · Low confidence | Yeda Research and Development Co. Ltd. | Grace period ended Nov 18, 2026 lapse expected | Low confidence | |
| US 10,512,699 | Optical Method for the Detection of Alzheimer's Disease Using Curcumin In force · Medium confidence | Cedars-Sinai Medical Center | In force | Medium confidence | |
| US 9,109,029 | Compositions Comprising Soluble CD84 or ANTI-CD84 Antibodies and Methods for Diagnosing and Treating B-Cll In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 9,421,228 | Use of Anti Third Party Central Memory T Cells for Anti-Leukemia/Lymphoma Treatment In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 9,738,872 | Anti Third Party Central Memory T Cells, Methods of Producing Same and Use of Same in Transplantation and Disease Treatment In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.